According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Therapeutics Inc.
Globus Medical Inc (GMED, Financial): CEO, 10% Owner David C Paul sold 1,922,000 Shares
CEO, 10% Owner of Globus Medical Inc (GMED, Financial) David C Paul sold 1,922,000 shares on 03/19/2015 at an average price of $25. Globus Medical Inc was incorporated in Delaware in March 3, 2003. Globus Medical Inc has a market cap of $2.33 billion; its shares were traded at around $24.58 with a P/E ratio of 25.20 and P/S ratio of 4.95.
Globus Medical Inc. reported their 2014 annual results. The Company announced sales of $474.4 million and net income of $92.5 million.
CEO, 10% Owner David C Paul sold 1,922,000 shares of GMED stock on 03/19/2015 at the average price of 25. President and COO David M Demski and Senior VP, Operations David D Davidar together sold 71,010 shares of GMED stock in October and February.
Diplomat Pharmacy Inc (DPLO, Financial): Chairman and CEO, 10% Owner Philip R Hagerman sold 1,801,000 Shares
Chairman and CEO, 10% Owner of Diplomat Pharmacy Inc (DPLO, Financial) Philip R Hagerman sold 1,801,000 shares on 03/25/2015 at an average price of $29. Diplomat Pharmacy Inc was founded in 1975. The Company is a specialty pharmacy company engaged in improving the lives of patients with complex chronic diseases. Diplomat Pharmacy Inc has a market cap of $1.74 billion; its shares were traded at around $33.72 with a P/E ratio of 571.70 and P/S ratio of 0.59.
Diplomat Pharmacy Inc. recognized revenues of $2.2 billion and net income of $4.3 million in its 2014 full year results.
Chairman and CEO, 10% Owner Philip R Hagerman sold 8,509,333 shares of DPLO stock in October and March. CFO Sean Whelan bought 2,000 shares of DPLO stock on 10/09/2014 at the average price of 13. Director David C Dreyer and SVP of Sales & Business Dev Atheer A Kaddis together bought 5,034 shares of DPLO stock in October and March. EVP of Operations Jeffrey M Rowe sold 600,000 shares of DPLO stock in March.
Zendesk Inc (ZEN, Financial): Chairman and CEO Mikkel Svane sold 600,000 Shares
Chairman and CEO of Zendesk Inc (ZEN, Financial) Mikkel Svane sold 600,000 shares on 03/24/2015 at an average price of $21.76. Zendesk Incw was incorporated in Delaware in April 2009. Zendesk Inc has a market cap of $1.68 billion; its shares were traded at around $22.22 with and P/S ratio of 9.37.
Zendesk Inc. announced its 2014 fourth quarter financial results with revenues of $38.5 million and net loss of $17.5 million.
Chairman and CEO Mikkel Svane sold 600,000 shares of ZEN stock on 03/24/2015 at the average price of 21.76. SVP and CFO Alan J Black sold 40,000 shares of ZEN stock in February and March. SVP Operations Anne Raimondi, Director, 10% Owner Devdutt Yellurkar, and SVP of Product Development Adrian Mcdermott together sold 437,294 shares of ZEN stock in March.
Amicus Therapeutics Inc (FOLD, Financial): Chairman & CEO John F Crowley sold 268,322 Shares
Chairman & CEO of Amicus Therapeutics Inc (FOLD, Financial) John F Crowley sold 268,322 shares on 03/20/2015 at an average price of $11.49. Amicus Therapeutics Inc incorporated under the laws of the State of Delaware on February 4, 2002. Amicus Therapeutics Inc has a market cap of $1.05 billion; its shares were traded at around $10.96 with and P/S ratio of 666.59. Amicus Therapeutics Inc had an annual average earnings growth of 20.10% over the past 5 years.
Amicus Therapeutics Inc. declared its 2014 annual results, which included revenues of $1.2 million and net loss of $68.9 million.
Chairman & CEO John F Crowley sold 357,322 shares of FOLD stock in December and March. CFO William D Baird III sold 35,235 shares of FOLD stock in October, November, and March. VP Clinical Ops & Data Mgmt Julie Yu, VP, Pharmacology & Biology Ken Valenzano, VP, Legal & IP Kenneth Peist, and VP, Regulatory Affairs John Kirk together sold 40,945 shares of FOLD stock in March.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.